Memphasys Ltd (AU:MEM) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Memphasys Ltd has announced a share purchase plan (SPP) where eligible shareholders can buy up to $30,000 in shares at a discounted rate, accompanied by an equal number of options. Targeting investors interested in an Australian emerging biotech firm, the SPP aims for those with a short to medium-term investment horizon and a tolerance for high-risk speculative investments. The company emphasizes that the investment does not guarantee income or capital protection, and stresses the importance of financial literacy for potential investors.
For further insights into AU:MEM stock, check out TipRanks’ Stock Analysis page.